FINWIRES · TerminalLIVE
FINWIRES

Paragon Care Says Infinity Group Receivership to Return 24-33% of Outstanding Exposure

By

Paragon Care (ASX:PGC) was advised by administrators that a preliminary estimated outcome analysis for the Infinity Retail Pharmacy Group administration indicates it will receive a distribution of about AU$11.7 million to AU$15.8 million, representing a recovery of around 24% to nearly 33% of its outstanding exposure, according to a Monday Australian bourse filing.

The company said it has already received a cash recovery of AU$3.4 million from the Australian Taxation Office relating to goods and services tax previously paid on the Infinity Group receivable.

Paragon Care expects fiscal year 2026 revenue of about AU$3.7 billion, with underlying earnings before interest, taxes, depreciation, and amortization in the range of AU$95 million to AU$100 million, it added.

Related Articles

Asia

Genrix Grants CQ Pharmaceutical Distribution Rights for Myeloma Drug in China, Hong Kong, Macau, Taiwan

Chongqing Genrix Biopharmaceutical (SHA:688443) granted C.Q. Pharmaceutical (SHE:000950) subsidiary Yaoyou Pharmaceutical exclusive development and distribution rights for the GR1803 drug across China and Hong Kong, Macau, and Taiwan.The agreement covers development such as clinical trials, research, and manufacturing, as well as sales, the filing said.The GR1803 velitumimumab drug is indicated for multiple myeloma, a rare form of blood cancer.Yaoyou will pay Genrix up to 600 million yuan in initial payment, listing milestone, and technology transfer milestone payments.Genrix will also be eligible to receive sales royalties of up to a minimum percentage of two digits.

SHA:688443SHE:000950
Asia

Xuan Wu Cloud's CFO Steps Down

Xuan Wu Cloud Technology's (HKG:2392) Chief Financial Officer Ge Ping resigned to devote more time to personal affairs effective May 31, according to a Friday Hong Kong bourse filing.

HKG:2392
Asia

Update: Xi'an Eswin Materials Technology to Invest Up to 40 Million Yuan in Glassmaker's Funding Round

Xi'an Eswin Materials Technology (SHA:688783) will invest up to 40 million yuan in a pre-A+ funding round for Zhuhai Yiyuan Technology, according to a Friday filing with the Shanghai bourse.Zhuhai Yiyuan Technology seeks to raise between 100 million yuan and 200 million yuan in a funding round.The glass manufacturer plans to use the proceeds for capacity expansion, equipment procurement, and technology upgrades.

SHA:688783